Literature DB >> 3365237

A new kinin moiety in human plasma kininogens.

T Mindroiu1, O A Carretero, D Proud, D Walz, A G Scicli.   

Abstract

Recently, we isolated a new kinin from human urine and tentatively identified it as [Ala3]-Lys-bradykinin. However, there were inconsistencies between the properties of the naturally occurring new kinin and synthetic [Ala3]-Lys-bradykinin. In the present work, we determined whether the new kinin was released from human plasma kininogen, and further investigated the structure of the new kinin. After incubation of plasma (n = 6) with human urinary kallikrein, kinins were separated by HPLC and measured by RIA. The new kinin and Lys-bradykinin were found representing 23 +/- 3 and 76 +/- 6%, respectively, of total kinins released (2.0 +/- 0.4 micrograms/ml). The new kinin was also released from both purified low- and high-molecular-weight kininogens, representing 40-42% of total kinins released. Amino acid sequencing and composition analysis indicated that the structure of the new kinin was [Hyp3]-Lys-bradykinin (Lys-Arg-Pro-Hyp-Gly-Phe-Ser-Pro-Phe-Arg) and not [Ala3]-Lys-bradykinin. We conclude that an important proportion of human kininogens contain hydroxyproline instead of proline in position three of the bradykinin moiety.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3365237     DOI: 10.1016/s0006-291x(88)80068-8

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  Structure-activity studies on bradykinin and related peptides: agonists.

Authors:  N E Rhaleb; G Drapeau; S Dion; D Jukic; N Rouissi; D Regoli
Journal:  Br J Pharmacol       Date:  1990-03       Impact factor: 8.739

2.  Degradation pathway of kinins in tumor ascites and inhibition by kininase inhibitors: analysis by HPLC.

Authors:  Y Matsumura; H Maeda; H Kato
Journal:  Agents Actions       Date:  1990-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.